Vanguard Global Advisers »

Nrx Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $24k 5.8k 4.09

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Rbc Cad (RY)

View all positions for Vanguard Global Advisers

Top funds holding Nrx Pharmaceuticals

Vanguard Capital Management
Citadel Advisors
Ameriprise Financial
Balyasny Asset Management
AdvisorShares Investments
Commonwealth Equity Services
UBS Group
Geode Capital Management
Susquehanna International
BlackRock
Marshall Wace
Vanguard Fiduciary Trust
Jane Street
Bleakley Financial Group
Hrt Financial

View all funds holding Nrx Pharmaceuticals